Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of bleeding disorders in the elderly.
Kruse-Jarres R, Quon D, Schramm W, Dolan G. Kruse-Jarres R, et al. Among authors: schramm w. Haemophilia. 2012 May;18 Suppl 2:37-45. doi: 10.1111/j.1365-2516.2012.02798.x. Haemophilia. 2012. PMID: 22530577
European principles of haemophilia care.
Colvin BT, Astermark J, Fischer K, Gringeri A, Lassila R, Schramm W, Thomas A, Ingerslev J; Inter Disciplinary Working Group. Colvin BT, et al. Among authors: schramm w. Haemophilia. 2008 Mar;14(2):361-74. doi: 10.1111/j.1365-2516.2007.01625.x. Epub 2008 Jan 30. Haemophilia. 2008. PMID: 18248408
Unresolved issues in prophylaxis.
Brown SA, Aledort LM, Astermark J, Berntorp E, van den Berg M, Blanchette V, Donfield S, Gringeri A, Hilgartner M, Kulkarni R, Leissinger C, Negrier C, Nuss R, Petterson H, Petrini P, Poulios N, Schramm W; Round Table Group. Brown SA, et al. Among authors: schramm w. Haemophilia. 2002 Nov;8(6):817-21. doi: 10.1046/j.1365-2516.2002.00685.x. Haemophilia. 2002. PMID: 12410654 No abstract available.
Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies.
Peyvandi F, Berger K, Seitz R, Hilger A, Hecquet ML, Wierer M, Buchheit KH, O'Mahony B, Bok A, Makris M, Mansmann U, Schramm W, Mannucci PM. Peyvandi F, et al. Among authors: schramm w. Haematologica. 2020 Aug;105(8):2038-2043. doi: 10.3324/haematol.2019.242735. Epub 2020 May 28. Haematologica. 2020. PMID: 32467138 Free PMC article.
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. Berntorp E, et al. Among authors: schramm w. Haemophilia. 2003 May;9 Suppl 1:1-4. doi: 10.1046/j.1365-2516.9.s1.17.x. Haemophilia. 2003. PMID: 12709030
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.
Gringeri A, Leissinger C, Cortesi PA, Jo H, Fusco F, Riva S, Antmen B, Berntorp E, Biasoli C, Carpenter S, Kavakli K, Morfini M, Négrier C, Rocino A, Schramm W, Windyga J, Zülfikar B, Mantovani LG. Gringeri A, et al. Among authors: schramm w. Haemophilia. 2013 Sep;19(5):736-43. doi: 10.1111/hae.12178. Epub 2013 Jun 4. Haemophilia. 2013. PMID: 23731246 Clinical Trial.
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria.
Pollmann H, Externest D, Ganser A, Eifrig B, Kreuz W, Lenk H, Pabinger I, Schramm W, Schwarz TF, Zimmermann R, Zavazava N, Oldenburg J, Klamroth R. Pollmann H, et al. Among authors: schramm w. Haemophilia. 2007 Mar;13(2):131-43. doi: 10.1111/j.1365-2516.2006.01416.x. Haemophilia. 2007. PMID: 17286765
416 results